Synthesis and In Vivo Evaluation of Halogenated N,N-Dimethyl-2-(2′-amino-4′-hydroxymethylphenylthio)benzylamine Derivatives as PET Serotonin Transporter Ligands
- 18 December 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (2), 271-281
- https://doi.org/10.1021/jm0707929
Abstract
N,N-Dimethyl-2-(2′-amino-4′-hydroxymethylphenylthio)benzylamine (38), substituted on ring A, was reported to display high binding affinity and selectivity to the human brain serotonin transporter (SERT). In an attempt to explore the potential of compounds substituted on ring B of the phenylthiophenyl core structure, three derivatives of 38 were synthesized: N,N-dimethyl-2-(2′-amino-4′-hydroxymethyl-phenylthio)-5-fluorobenzylamine (35), N,N-dimethyl-2-(2′-amino-4′-hydroxymethyl-phenylthio)-5-bromobenzylamine (36), and N,N-dimethyl-2-(2′-amino-4′-hydroxymethyl-phenylthio)-5-iodobenzylamine (37). The in vitro binding studies in cells transfected with human SERT, norepinephrine transporter (NET), and dopamine transporter (DAT) showed that 35, 36, and 37 exhibited high SERT affinity with Kis (SERT) = 1.26, 0.29, and 0.31 nM (vs [3H]citalopram), respectively. [11C]-(35), [11C]-(36), and [11C]-(37) were prepared by methylation of their monomethyl precursors 16, 17, and 18, with [11C]iodomethane in 28, 11, and 14% radiochemical yields, respectively. The microPET images of [11C]-(35), [11C]-(36), and [11C]-(37) showed high uptake in the monkey brain regions rich in SERT with peak midbrain to cerebellum ratios of 3.41, 3.24, and 3.00 at 85 min post-injection, respectively. In vivo bindings of [11C]-(35), [11C]-(36), and [11C]-(37) were shown to be specific to the SERT as displacement with citalopram (a potent SERT ligand) reduced radioactivity in SERT-rich regions to the cerebellum level. These results suggest that [11C]-(35), [11C]-(36), and [11C]-(37) could be potential agents for mapping human SERT by PET and radiolabeling 37 with iodine-123, which could afford the first SPECT SERT imaging agent exhibiting fast kinetics.Keywords
This publication has 38 references indexed in Scilit:
- Functional Imaging of Mood and Anxiety DisordersJournal of Neuroimaging, 2006
- Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: Response to acute serotonin deficiencyBiological Psychiatry, 2005
- Serotonin transporter and GABA(A) alpha 6 receptor variants are associated with neuroticismBiological Psychiatry, 2004
- PET examination of [11C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporterNuclear Medicine and Biology, 2002
- Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input FunctionsJournal of Cerebral Blood Flow & Metabolism, 2000
- Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitorBiological Psychiatry, 2000
- PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporterNuclear Medicine and Biology, 1999
- Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional ImagingNeuropsychopharmacology, 1998
- Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652Synapse, 1995
- Asymmetric induction in an enammonium-iminium rearrangement. Mechanistic insight via NMR, deuterium labeling, and reaction rate studies. Application to the stereoselective synthesis of pyrroloisoquinoline antidepressantsJournal of the American Chemical Society, 1990